TMT1A and neoplasm: We evaluated the prognostic value of METTL7A, genetic alteration, correlation with clinical features, microsatellite instability (MSI), tumor mutational burden (TMB), immune cell infiltration, and immune therapy-associated genes across 33 types of cancers in TCGA.